Biol Reprod 2009,
Tanwar, Pradeep S; Lee, Ho-Joon; Zhang, LiHua; Zukerberg, Lawrence R; Taketo, Makoto M; Rueda, Bo R; Teixeira, Jose M
Leiomyomas and other mesenchymally derived tumors are the most common neoplasms of the female reproductive tract. Presently, very little is known about the etiology and progression of these tumors, which are the primary indication for hysterectomies. Dysregulated WNT signaling through beta-catenin is a well-established mechanism for tumorigenesis. We have developed a mouse model that expresses constitutively activated beta-catenin in uterine mesenchyme driven by the expression of Cre recombinase knocked into the Müllerian-inhibiting substance type II receptor promoter locus to investigate its effects on uterine endometrial stroma and myometrium. These mice show myometrial hyperplasia and develop mesenchymal tumors with 100% penetrance that exhibit histological and molecular characteristics of human leiomyomas and endometrial stromal sarcomas. By immunohistochemistry, we also show that both transforming growth factor beta and the mammalian target of rapamycin are induced by constitutive activation of beta-catenin. The prevalence of the tumors was greater in multiparous mice, suggesting that their development may be a hormonally driven process or that changes in uterine morphology during pregnancy and after parturition induce injury and repair mechanisms that stimulate tumorigenesis from stem/progenitor cells, which normally do not express constitutively activated beta-catenin. Additionally, adenomyosis and endometrial gland hyperplasia were occasionally observed in some mice. These results show evidence suggesting that dysregulated, stromal, and myometrial WNT/beta-catenin signaling has pleiotropic effects on uterine function and tumorigenesis.
Diseases/Pathways annotated by Medline MESH:
Cell Transformation, Neoplastic, Endometriosis, Leiomyoma, Uterine Diseases, Uterine Neoplasms
Document information provided by NCBI PubMed
Text Mining Data
transforming growth factor beta → beta-catenin: " By immunohistochemistry, we also show that both transforming growth factor beta
and the mammalian target of rapamycin are induced
by constitutive activation of beta-catenin
beta-catenin → mammalian target of rapamycin: " By immunohistochemistry, we also show that both transforming growth factor beta and the mammalian target of rapamycin are induced by constitutive activation of beta-catenin "
Manually curated Databases
No curated data.